Financial information, reports, calendar and more

Shareholder’s meetings

2017

EGM November 23, 2017
Notice (Swe: Fullständig kallelse)
Power of Attorney (Swe: Fullmakt)
Additional material (Swe: Emission, kap 13)

AGM June 29, 2017
Notice (Swe: Fullständig kallelse)
Power of Attorney (Swe: Fullmakt)


2016

AGM May 20, 2016
Notice (Swe: Fullständig kallelse)
Power of Attorney (Swe: Fullmakt)

EGM March 14, 2016
Notice (Swe: Fullständig kallelse)
Power of Attorney (Swe: Fullmakt)


2015

AGM June 23, 2015
Notice (Swe: Fullständig kallelse)
Power of Attorney (Swe: Fullmakt)


2014

AGM May 8, 2014
Notice (Swe: Fullständig kallelse)
Power of Attorney (Swe: Fullmakt)


2013

EGM August 20, 2013
Notice (Swe: Fullständig kallelse)
Power of Attorney (Swe: Fullmakt)

AGM June 28, 2013
Notice (Swe: Fullständig kallelse)
Power of Attorney (Swe: Fullmakt)


2012

AGM April 20, 2012
Notice (Swe: Fullständig kallelse)
Power of Attorney (Swe: Fullmakt)

Affibody in short

Affibody is a Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.

Upcoming reports Financial calendar

  • Year-end report (February 24, 2017)